Investor Overview

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.
Press Releases
  • July 22, 2020 at 4:05 PM EDT
    SUNNYVALE, Calif. , July 22, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020 . In addition, she will serve on the Board's Nominating and Corporate Governance Committee .
  • July 16, 2020 at 7:00 AM EDT
    SUNNYVALE, Calif. , July 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020 . Management will host a conference call to review the
Annual Reports
Filing date Form